This application requests support for eight positions for physicians committed to a career in cancer research. The intent of the training grant is to provide in-depth didactic and project-oriented research experience for both physicians who have participated in clinical training programs related to cancer. Candidates will be sought primarily from the large pool of clinical trainees in surgery, medical oncology, pediatric oncology, and radiation therapy at the Massachusetts General Hospital and will work in research groups at the MGH and affiliated institutions. The program is based on the rapidly evolving model of multi-disciplinary, disease-based research and patient care at the MGH and the Dana Farber/Harvard Cancer Center, of which the MGH is a member. In this model, disease-based clinical programs in lung, breast, colon, and other cancers link to, and collaborate with investigators from basic and population science laboratories to expedite the translation of research findings into useful clinical applications. The core laboratories and clinical trials program of the DF/HCC, including dedicated core laboratories in molecular pathology for each disease program, are available to all investigators and their trainees in support of their research. In this disease-based model, all medical and surgical specialties participate equally in research planning and project development. Our wish is to train the next generation of pediatric and medical oncologists, surgical oncologists, and radiation therapists in the basic methods and concepts of cancer research, strengthening the ties between laboratory and clinic. Responding to the encouragement of our previous reviews, the current proposal seeks to expand and strengthen this concept of multidisciplinary training. Thus the proposal emphasizes participation of all specialties and research disciplines in the leadership and planning of the program, in the selection of candidates, and in the monitoring of the progress of trainees.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA071345-08
Application #
6771875
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1997-08-01
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
8
Fiscal Year
2004
Total Cost
$480,674
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Jalbut, Marla M; Brunner, Andrew M; Amrein, Philip C et al. (2018) Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia. Leuk Lymphoma 59:988-991
Sahin, Ayguen; Sanchez, Carlos; Bullain, Szofia et al. (2018) Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. PLoS One 13:e0199414
Spring, Laura M; Marshall, Megan R; Warner, Erica T (2017) Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014. Cancer 123:401-409
Micalizzi, Douglas S; Haber, Daniel A; Maheswaran, Shyamala (2017) Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells. Mol Oncol 11:770-780
Spring, Laura; Greenup, Rachel; Niemierko, Andrzej et al. (2017) Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. J Natl Compr Canc Netw 15:1216-1223
Spring, Laura M; Zangardi, Mark L; Moy, Beverly et al. (2017) Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Oncologist 22:1039-1048
Perry, Ashley M; Brunner, Andrew M; Zou, Tao et al. (2017) Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study. Cancer 123:2561-2569
Brunner, Andrew M; Hobbs, Gabriela; Jalbut, Marla M et al. (2016) A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database. Leuk Lymphoma 57:1197-200
Brunner, Andrew M; Steensma, David P (2016) Myelodysplastic syndrome associated with acquired beta thalassemia: ""BTMDS"". Am J Hematol 91:E325-7
Nipp, Ryan D; Greer, Joseph A; El-Jawahri, Areej et al. (2016) Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer. Oncologist 21:119-26

Showing the most recent 10 out of 66 publications